Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF AUGUST 06, 2009 FBO #2812
SOLICITATION NOTICE

66 -- Chain Reaction Sytem

Notice Date
8/4/2009
 
Notice Type
Combined Synopsis/Solicitation
 
NAICS
423450 — Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
 
Contracting Office
Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
 
ZIP Code
20857-0001
 
Solicitation Number
FDA-09-1056776
 
Point of Contact
Karen R. Petty, Phone: 301-827-8774
 
E-Mail Address
karen.petty@fda.hhs.gov
(karen.petty@fda.hhs.gov)
 
Small Business Set-Aside
Total Small Business
 
Description
Synopsis: This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR 12.6. This announcement constitutes the only solicitation and a written solicitation will not be issued. This synopsis, NAICS code 334516, is to notify contractors that the Food and Drug Administration (FDA) is seeking competition of this requirement in accordance with FAR Part 13.106 for the following statement of work, under the simplified acquisition procedures. Under the simplified acquisition procedures and the resultant purchase order will include all applicable provisions and clauses in effect through the Federal Acquisition Circular 05-35. This synopsis is designated for 100% Small Business Set Aside competition for a firm fixed-price purchase order. Prospective offerors are responsible for monitoring the FedBizOpps website for the release of any amendments to this solicitation. Hard copies will be provided to individuals eligible under the Americans with Disabilities Act and Rehabilitation Act upon request. This combined synopsis solicitation is issued as a Request for Quotations (RFQ). The FDA intends to award a purchase order for a Real time Polymerase Chain Reaction System (brand name or equal. Specifications for a Real time Polymerase Chain Reaction System include: Equipment: Product No. 185-5096 Model: CFX96 Real-Time Polymerase Chain Reaction System: Modular thermal cycler platform, includes C1000 thermal cycler chassis, CFX96 optical reaction module, CFX Manager software, cables, reagent and consumable samples Equipment: COMPUTER LAPTOP for software housing and analysis Software: Beacon Designer Probe/Primer (brand name or equal) –for probe and primer design for the machine. EVALUATION AND AWARD: Award will be made to the party whose quote offers the best value to the Government, technical, price, and other factors considered. The Government may award this purchase order to other than the lowest price technically acceptable quote. The Government will evaluate information based on the following evaluation criteria: 1) Technical Capability factor "Meeting or Exceeding the Requirement," (2) Past performance and 3) Price-- Technical Capability is significantly more important than price. It is the responsibility of the contractor to be familiar with the applicable clauses and provisions. The clauses may be accessed in full text at these addresses: www.acqnet.gov. The provision 52.212-1, Instructions to Offerors-Commercial applies to this acquisition. Offerors should complete their representations and certifications at Online Representations and Certifications Application (ORCA) at http://orca.bpn.gov. The Food and Drug Administration requests responses from qualified sources capable of providing these services in accordance with the attached. FAR provision 52.212-2, Evaluation-Commercial Items applies. FAR Provision, 52.212-3, Offeror Representations and Certifications applies, if the contractor is not registered in ORCA, the vendor shall complete and submit with offer. FAR Clauses 52.212-4 and 52.212-5 apply. The FAR clauses cited in the clause are applicable to this acquisition: 52.219-28, 52.222-3, 52.222-21, 52.222-26, 52.222-36, 52.222-36, 52.222-50, 52.225-13, 52.232-33, and 52.239-1. Government reserves the right to award a purchase order without discussion if the Contracting Officer determines that the initial offer(s) is/are providing the Best Value and discussions are not necessary. The total number of pages for the technical plan is not expected to exceed twenty-five (25) pages in length CCR: Vendors must be registered in the Central Contractor Register (CCR) prior to the award of a contract. You may register by going to www.ccr.gov. All questions are to be submitted via email to karen.petty@fda.hhs.gov no later than August 7, 2009 4:30 PM EST. NO PHONE CALLS WILL BE ACCEPTED. This is a REQUEST FOR QUOTATION (RFQ). All quotations are due, via email to: karen.petty@fda.hhs.gov no later than 4:30pm, EST on August 13, 2009. FDA anticipates an award soon after the response date.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-09-1056776/listing.html)
 
Place of Performance
Address: Food and Drug Administration, 8401 Muirkirk Road, Laurel, Maryland, 20708, United States
Zip Code: 20708
 
Record
SN01899136-W 20090806/090805000830-4d5eb2a746645038048b60b7ed69f95b (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  © 1994-2020, Loren Data Corp.